NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Peanut Allergy Patch Shows 47% Success Rate in Children

DBV Technologies' (DBVT) VIASKIN Peanut patch shows significant success in treating peanut allergies in children aged 4-7, with nearly half of participants responding positively after one year.

Peanut Allergy Patch Shows 47% Success Rate in Children
Photo by Vladislav Nikonov on Unsplash
Already have an account? Sign in.
12/16/2025 · 4:38 PM
DBVT
/ Don’t stop at just one post.

Related↓

83% of Kids Tolerate More Peanut with VIASKIN Patch in Landmark Study
03/02/2026 · 11:09 AM

83% of Kids Tolerate More Peanut with VIASKIN Patch in Landmark Study

DBV Technologies reveals new VITESSE Phase 3 data at AAAAI 2026: 83% of kids on VIASKIN Peanut Patch increased safe peanut dose vs 48% on placebo, with excellent safety.

/ Subscriber only
/ Read more

Feed↓

Carriers Drop, Tower Stocks Rise on SpaceX Wireless Network Plans
Featured/ 10/22/2026 · 5:58 PM

SpaceX Targets 80,000 Cell Sites in Push to Become Fourth U.S. Carrier

Major carriers traded lower after Bloomberg reported SpaceX is seeking access to 80,000 cell sites for a fourth wireless network.

/ Subscriber only
FDA Lifts Clinical Hold on Aardvark’s ARD-101 for Prader-Willi Syndrome
10/22/2026 · 5:38 PM

FDA Lifts Clinical Hold on Aardvark’s ARD-101 for Prader-Willi Syndrome

The FDA lifted the clinical hold on ARD-101, allowing Aardvark Therapeutics to resume development for Prader-Willi Syndrome after cardiac safety studies.

/ Subscriber only
Western Digital Beats Earnings and Raises Outlook, but Stock Slides on Broader AI Selloff
10/22/2026 · 5:03 PM

Western Digital Beats Earnings and Raises Outlook, but Stock Slides on Broader AI Selloff

WDC beat revenue and EPS forecasts and hiked its dividend, but shares dropped as the AI selloff continued after hours.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI